When will the genomics investment pay off for antibacterial discovery?

Biochemical Pharmacology

Volumn 71, Issue 7, 2006, Pages 1096-1102

  Mills, Scott D ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Antibacterial; Bioinformatic; Genomic; Resistance; Screening; Target

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; DAPTOMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; MOXIFLOXACIN; NORFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; BACTERIAL GENETICS; BIOINFORMATICS; DRUG RESEARCH; DRUG TARGETING; GENE SEQUENCE; HIGH THROUGHPUT SCREENING; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE;

EID: 33644557421     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.11.025     Document Type: Note

References (67)

1. S.J. Projan Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 6 2003 427 430
2. B. Spellberg, J.H. Powers, E.P. Brass, L.G. Miller, and J.E. Edwards Trends in antimicrobial drug development: implications for the future Clin Infect Dis 38 2004 1279 1286
3. K.M. Overbye, and J.F. Barrett Antibiotics: where did we go wrong? Drug Discov Today 10 2005 45 52
4. S.R. Norrby, C.E. Nord, and R. Finch Lack of development of new antimicrobial drugs: a potential serious threat to public health Lancet Infect Dis 5 2005 115 119
5. Infectious Diseases Society of America. Bad Bugs, No Drugs. As antibiotic discovery stagnates - A public health crisis brews; 2004. 35 p.
6. R.C. Moellering Linezolid: the first oxazolidinone antimicrobial Ann Intern Med 138 2003 135 142
7. K.L. LaPlante, and M.J. Rybak Daptomycin - a novel antibiotic against Gram-positive pathogens Expert Opin Pharmacother 5 2004 2321 2331
8. C. Walsh Where will new antibiotics come from? Nat Rev Microbiol 1 2003 65 70
9. G. Sakoulas, P.A. Moise-Broder, J. Schentag, A. Forrest, R.C. Moellering, and G.M. Eliopoulos Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2004 2398 2402
10. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb Mortal Wkly Rep 2002;51:565-67.
11. R.D. Gonzales, P.C. Schreckenberger, M.B. Graham, S. Kelkar, K. DenBesten, and J.P. Quinn Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid Lancet Infect Dis 357 2001 1179
12. S. Tsiodras, H.S. Gold, G. Sakoulas, G.M. Eliopoulos, C. Wennersten, and L. Venkataraman Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet Infect Dis 358 2001 207 208
13. A. Mangili, I. Bica, D.R. Snydman, and D.H. Hamer Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 40 2005 1058 1060
14. R.D. Fleischmann, M.D. Adams, O. White, R.A. Clayton, E.F. Kirkness, and A.R. Kerlavage Whole-genome random sequencing and assembly of Haemophilus influenzae Rd Science 269 1995 496 512
15. C.M. Fraser, J.D. Gocayne, O. White, M.D. Adams, R.A. Clayton, and R.D. Fleischmann The minimal gene complement of Mycoplasma genitalium Science 270 1995 397 403
16. E.V. Koonin How many genes can make a cell: the minimal-gene-set concept Annu Rev Genomics Hum Genet 1 2000 99 116
17. R. Gil, F.J. Silva, J. Pereto, and A. Moya Determination of the core of a minimal bacterial gene set Microbiol Mol Biol Rev 68 2004 518 537
18. R.A. Alm, L.S. Ling, D.T. Moir, B.L. King, E.D. Brown, and P.C. Doig Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori Nature 397 1999 176 180
19. The National Center for Biotechnology Information's Entrez Genome Project web page, http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi.
20. J.E. Cassat, P.M. Dunman, F. McAleese, E. Murphy, S.J. Projan, and M.S. Smeltzer Comparative genomics of Staphylococcus aureus musculoskeletal isolates J Bacteriol 187 2005 576 592
21. J.A. Lindsay, and MT.G. Holden Staphylococcus aureus: superbug, supergenome? Trends Microbiol 12 2004 378 385
22. J.C. Venter, M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, and G.G. Sutton The Sequence of the human genome Science 291 2001 1304 1351
23. E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, M.C. Zody, and J. Baldwin Initial sequencing and analysis of the human genome Nature 409 2001 860 921
24. A.K. Bansal Bioinformatics in microbial biotechnology - a mini review Microb Cell Factories 4 2005 19
25. Alm EJ, Huang KH, Price MN, Koche RP, Keller K, Dubchak IL, et al. The MicrobesOnline Web site for comparative genomics. Genome Res 2005;15:1015-22 [ http://www.microbesonline.org ].
26. The Institute for Genomic Research's Comprehensive Microbial Resource web page, www.tigr.org.
27. P. Ball Epidemiology and treatment of chronic bronchitis and its exacerbations Chest 108 1995 43 52
28. S.M. Wong, and J.J. Mekalanos Genetic footprinting with mariner-based transposition in Pseudomonas aeruginosa Proc Natl Acad Sci USA 97 2000 10191 10196
29. R.S. Hare, S.S. Walker, T.E. Dorman, J.R. Greene, L.M. Guzman, and T.J. Kenney Genetic footprinting in bacteria J Bacteriol 183 2001 1694 1706
30. B.J. Akerley, E.J. Rubin, V.L. Novick, K. Amaya, N. Judson, and J.J. Mekalanos A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae Proc Natl Acad Sci USA 99 2002 966 971
31. Y. Ji, B. Zhang, S.F. Van Horn, P. Warren, G. Woodnut, and MKR Burnham Identification of critical Staphylococcal genes using conditional phenotypes generated by antisense RNA Science 293 2001 2266 2269
32. R.A. Forsyth, R.J. Haselbeck, K.L. Ohlsen, R.T. Yamamoto, H. Xu, and J.D. Trawick A genome-wide strategy for the identification of essential genes in Staphylococcus aureus Mol Microbiol 43 2002 1387 1400
33. J.A. Thanassi, S.L. Hartman-Neumann, T.J. Dougherty, B.A. Dougherty, and M.J. Pucci Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae Nucleic Acids Res 30 2002 3152 3162
34. J.H. Song, K.S. Ko, J.Y. Lee, J.Y. Baek, W.S. Oh, and H.S. Yoon Identification of essential genes in Streptococcus pneumoniae by allelic replacement mutagenesis Mol Cells 19 2005 365 374
35. C.A. Hutchison, S.N. Peterson, S.R. Gill, R.T. Cline, O. White, and C.M. Fraser Global transposon mutagenesis and a minimal mycoplasma genome Science 286 1999 2165 2169
36. K. Kobayashi, S.D. Ehrlich, A. Albertini, G. Amati, K.K. Andersen, and M. Arnaud Essential Bacillus subtillis genes Proc Natl Acad Sci USA 100 2003 4678 4683
37. A. Link, D. Phillips, and G. Church Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization J Bacteriol 179 1997 6228 6237
38. M. Xia, R.D. Lunsford, D. McDevitt, and S. Lordanescu Rapid method for the identification of essential genes in Staphylococcus aureus Plasmid 42 1999 144 149
39. A. Saeed-Koithe, W. Yang, and S.D. Mills Development of an essential gene knockout and complementation system for Haemophilus influenzae using riboflavin synthase (ribC) as a model Appl Environ Microbiol 70 2004 4136 4143
40. E. Dervyn, C. Suski, R. Daniel, C. Bruand, J. Chapuis, and J. Errington Two essential DNA polymerases at the bacterial replication fork Science 294 2001 1716 1719
41. P.F. Chan, K.M. O'Dwyer, L.M. Palmer, J.D. Ambrad, K.A. Ingraham, and C. So Characterization of a novel fucose regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae J Bacteriol 185 2003 2051 2058
42. L. Miesel, J. Greene, and T.A. Black Genetic strategies for antibacterial drug discovery Nat Rev Genet 4 2003 442 456
43. I.T. Paulsen, J. Chen, K.E. Nelson, and MH. Saier Jr. Comparative genomics of microbial drug efflux systems J Mol Microbiol Biotechnol 3 2001 145 150
44. J.M. Clements, F. Coignard, I. Johnson, S. Chandler, S. Palan, and A. Waller Antibacterial actives and characterization of novel inhibitors of LpxC Antimicrob Agents Chemother 46 2002 1793 1799
45. J.A. DeVito, J.A. Mills, V.G. Liu, A. Agarwal, C.F. Sizemore, and Z. Yao An array of target-specific screening strains for antibacterial discovery Nat Biotechnol 20 2002 478 483
46. H.P. Fischer, N.A. Brunner, B. Wieland, J. Paquette, L. Macko, and K. Ziegelbauer Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery Genome Res 14 2004 90 98
47. W.H. Tsui, G. Yim, H.H. Wang, J.E. McClure, M.G. Surette, and J. Davies Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome Chem Biol 11 2004 1307 1316
48. S.D. Mils, W. Yang, and K. MacCormack Molecular characterization of benzimidazole resistance in Helicobacter pylori Antimicrob Agents Chemother 48 2004 2524 2530
49. C.G. Lerner, S.J. Kakavas, C. Wagner, R.T. Chang, and P.J. Merta Novel approach to mapping of resistance mutations in whole genomes by using restriction enzyme modulation of transformation efficiency Antimicrob Agents Chemother 49 2005 2767 2777
50. C. Freiberg, H.P. Fischer, and N.A. Brunner Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants Antimicrob Agents Chemother 49 2005 749 759
51. B. Hutter, C. Schaab, S. Albrecht, M. Borgmann, N.A. Brunner, and C. Freiberg Prediction of mechanisms of action of antibacterial compounds by gene expression profiling Antimicrob Agents Chemother 48 2004 2838 2844
52. B. Liu, S. Li, and J. Hu Technological advances in high-throughout screening Am J Pharmacogenomics 4 2004 263 276
53. P. Gribbon, and A. Sewing High-throughput drug discovery: what can we expect from HTS? Drug Discov Today 10 2005 18 22
54. D.J. Payne The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents Drug News Perspect 17 2004 187 194
55. Z. Me, C. Perretta, J. Lu, Y. Su, S. Margosiak, and K.S. Gajiwala Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents J Med Chem 48 2005 1596 1609
56. C.J. Hackbarth, D.Z. Chen, J.G. Lewis, K. Clark, J.B. Mangold, and J.A. Cramer N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity Antimicrob Agents Chemother 46 2002 2752 2764
57. D. Chen, C. Hackbarth, Z.J. Ni, C. Wu, W. Wang, and R. Jain Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach Antimicrob Agents Chemother 48 2004 250 261
58. R.L. Jarvest, J.M. Berge, V. Berry, H.F. Boyd, M.J. Brown, and J.S. Elder Nanamolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against Gram-positive pathogens J Med Chem 45 2002 1959 1962
59. M.J. Herrgard, M.W. Covert, and B.Ø. Palsson Reconstruction of microbial transcriptional regulatory networks Curr Opin Biotechnol 15 2004 70 77
60. M.W. Covert, E.M. Knight, J.L. Reed, M.J. Herrgård, and B.Ø. Palsson Integrating high-throughput and computational data elucidates bacterial networks Nature 429 2004 92 96
61. C.H. Schilling, M.W. Covert, I. Famili, G.M. Church, J.S. Edwards, and B.Ø. Palsson Genome-scale metabolic model of Helicobacter pylori 26695 J Bacteriol 184 2002 4582 4593
62. J.R. Fitzgerald, and J.M. Musser Evolutionary genomics of pathogenic bacteria Trends Microbiol 9 2001 547 553
63. N.A. Moran Microbial minimalism: genome reduction in bacterial pathogens Cell 108 2002 583 586
64. M.B. Schmid Seeing is believing: the impact of structural genomics on antimicrobial drug discovery Nat Rev Microbiol 2 2004 739 746
65. W. Ziebuhr, K. Xiao, B. Coulibaly, R. Schwarz, and T. Dandekar Pharmacogenomic strategies against resistance development in microbial infections Pharmacogenomics 5 2004 361 379
66. K.A. Phillips, and S.L. Van Bebber Measuring the value of pharmacogenomics Nat Rev Drug Discov 4 2005 500 509
67. T.W. Gant, and S.D. Zhang In pursuit of effective toxicogenomics Mutat Res 575 2005 4 16